Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Australie And NotLaura Silveira-Moriyama

List of bibliographic references

Number of relevant bibliographic references: 344.
Ident.Authors (with country if any)Title
000033 Jin-Sung Park [Australie] ; Nicholas F. Blair [Australie] ; Carolyn M. Sue [Australie]The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
000069 Perdita Cheshire [Australie] ; Scott Ayton [Australie] ; Kelly L. Bertram [Australie] ; Helen Ling [Royaume-Uni] ; Abi Li [Royaume-Uni] ; Catriona Mclean [Australie] ; Glenda M. Halliday [Australie] ; Sean S. O'Sullivan [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David I. Finkelstein [Australie] ; Elsdon Storey [Australie] ; David R. Williams [Australie]Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
000072 Monika Pötter-Nerger [Australie] ; Sendhil Govender ; Günther Deuschl ; Jens Volkmann ; J G ColebatchSelective changes of ocular vestibular myogenic potentials in Parkinson's disease.
000081 Teodora Chamova [Bulgarie] ; Dahlia Kancheva [Belgique] ; Velina Guergueltcheva [Bulgarie] ; Vanio Mitev [Bulgarie] ; Dimitar N. Azmanov [Australie] ; Luba Kalaydjieva [Australie] ; Albena Jordanova [Belgique] ; Ivailo Tournev [Bulgarie]Reply: Mutations in TUBB4A and spastic paraplegia.
000151 Heather Mccann [Australie] ; Heidi Cartwright [Australie] ; Glenda M. Halliday [Australie]Neuropathology of α-synuclein propagation and braak hypothesis.
000158 Kishore Raj Kumar [Australie]Mutations in hippocalcin and autosomal recessive dystonia: a role for perturbed calcium signaling?
000159 Kishore R. Kumar [Australie] ; Franca Vulinovic [Allemagne] ; Katja Lohmann [Allemagne] ; Jin-Sung Park [Australie] ; Susen Schaake [Allemagne] ; Carolyn M. Sue [Australie] ; Christine Klein [Allemagne]Mutations in TUBB4A and spastic paraplegia.
000167 Dahlia Kancheva [Belgique] ; Teodora Chamova [Bulgarie] ; Velina Guergueltcheva [Bulgarie] ; Vanio Mitev [Bulgarie] ; Dimitar N. Azmanov [Australie] ; Luba Kalaydjieva [Australie] ; Ivailo Tournev [Bulgarie] ; Albena Jordanova [Belgique]Mosaic dominant TUBB4A mutation in an inbred family with complicated hereditary spastic paraplegia.
000179 Daniela Berg [Allemagne] ; Ronald B. Postuma [Canada] ; Charles H. Adler [États-Unis] ; Bastiaan R. Bloem [Pays-Bas] ; Piu Chan [République populaire de Chine] ; Bruno Dubois [France] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Glenda Halliday [Australie] ; Lawrence Joseph [Canada] ; Anthony E. Lang [Canada] ; Inga Liepelt-Scarfone [Allemagne] ; Irene Litvan [États-Unis] ; Kenneth Marek [États-Unis] ; José Obeso [Espagne] ; Wolfgang Oertel [Allemagne] ; C Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Matthew Stern [États-Unis] ; Günther Deuschl [Allemagne]MDS research criteria for prodromal Parkinson's disease.
000180 Ronald B. Postuma [Canada] ; Daniela Berg [Allemagne] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] ; C Warren Olanow [États-Unis] ; Wolfgang Oertel [Allemagne] ; José Obeso [Espagne] ; Kenneth Marek [États-Unis] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; Glenda Halliday [Australie] ; Christopher G. Goetz [États-Unis] ; Thomas Gasser [Allemagne] ; Bruno Dubois [France] ; Piu Chan [République populaire de Chine] ; Bastiaan R. Bloem [Pays-Bas] ; Charles H. Adler [États-Unis] ; Günther Deuschl [Allemagne]MDS clinical diagnostic criteria for Parkinson's disease.
000181 Karen E. Murphy [Australie] ; Amanda M. Gysbers [Australie] ; Sarah K. Abbott [Australie] ; Adena S. Spiro [Australie] ; Akiko Furuta [Japon] ; Antony Cooper [Australie] ; Brett Garner [Australie] ; Tomohiro Kabuta [Japon] ; Glenda M. Halliday [Australie]Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.
000222 Gordon W. Duncan [Royaume-Uni] ; Michael J. Firbank [Royaume-Uni] ; Alison J. Yarnall [Royaume-Uni] ; Tien K. Khoo [Australie] ; David J. Brooks [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni]Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
000255 Inez Farag [Australie] ; Catherine Sherrington [Australie] ; Alison Hayes [Australie] ; Colleen G. Canning [Australie] ; Stephen R. Lord [Australie] ; Jacqueline C T. Close [Australie] ; Victor S C. Fung [Australie] ; Kirsten Howard [Australie]Economic evaluation of a falls prevention exercise program among people With Parkinson's disease.
000268 Norbert Schuff [États-Unis] ; I-Wei Wu [États-Unis] ; Shannon Buckley [États-Unis] ; Eric D. Foster [États-Unis] ; Christopher S. Coffey [États-Unis] ; Darren R. Gitelman [États-Unis] ; Susan Mendick [États-Unis] ; John Seibyl [États-Unis] ; Tanya Simuni [États-Unis] ; Yu Zhang [États-Unis] ; Joseph Jankovic [États-Unis] ; Christine Hunter [États-Unis] ; Caroline M. Tanner [États-Unis] ; Linda Rees [États-Unis] ; Stewart Factor [États-Unis] ; Daniela Berg [Allemagne] ; Isabel Wurster [Allemagne] ; Katharina Gauss [Allemagne] ; Fabienne Sprenger [Autriche] ; Klaus Seppi [Autriche] ; Werner Poewe [Autriche] ; Brit Mollenhauer [Allemagne] ; Susanne Knake [Allemagne] ; Zoltan Mari [États-Unis] ; Arita Mccoy [États-Unis] ; Madelaine Ranola [Australie] ; Kenneth Marek [États-Unis]Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.
000339 Kishore Raj Kumar [Australie] ; Victor S C. Fung [Australie]ADCY5 identified as a novel cause of benign hereditary chorea.
000363 Alana J. Muller [Australie] ; James M. Shine ; Glenda M. Halliday ; Simon J G. LewisVisual hallucinations in Parkinson's disease: theoretical models.
000372 Samuel D. Kim [Australie] ; Con Yiannikas ; Neil Mahant ; Steve Vucic ; Victor S C. FungTreatment of proximal upper limb tremor with botulinum toxin therapy.
000374 Daniela Berg [Allemagne] ; Ronald B. Postuma [Canada] ; Bastiaan Bloem [Pays-Bas] ; Piu Chan [République populaire de Chine] ; Bruno Dubois [France] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Glenda M. Halliday [Australie] ; John Hardy [Royaume-Uni] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis] ; Kenneth Marek [États-Unis] ; José Obeso [Espagne] ; Wolfgang Oertel [Allemagne] ; C Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Matthew Stern [États-Unis] ; Günther Deuschl [Allemagne]Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease
000394 Susannah Payne [Australie] ; Stephen Tisch ; Ian Cole ; Helen Brake ; Judy Rough ; Paul DarvenizaThe clinical spectrum of laryngeal dystonia includes dystonic cough: observations of a large series.
000395 Nadeeka N N W. Dissanayaka [Australie] ; Elizabeth White ; John D. O'Sullivan ; Rodney Marsh ; Nancy A. Pachana ; Gerard J. ByrneThe clinical spectrum of anxiety in Parkinson's disease.
000398 Glenda M. Halliday [Australie] ; James B. Leverenz [États-Unis] ; Jay S. Schneider [États-Unis] ; Charles H. Adler [États-Unis]The Neurobiological Basis of Cognitive Impairment in Parkinson'S Disease
000431 Samuel J. Bolitho [Australie] ; Ron R. Grunstein ; Sharon L. Naismith ; Kerri Melehan ; Simon J G. LewisReply: unified techniques are needed to diagnose REM sleep behavior disorder.
000512 Shekeeb S. Mohammad [Australie] ; Victor S C. Fung ; Padraic Grattan-Smith ; Deepak Gill ; Sekhar Pillai ; Sudarshini Ramanathan ; Fabienne Brilot ; Russell C. DaleMovement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies.
000513 Ainhi D. Ha [Australie] ; John D. Parratt ; Sangamithra Babu ; Samuel D. Kim ; Neil Mahant ; John O'Neill ; Jean-Pierre Halpern ; Victor S C. FungMovement disorders associated with CLIPPERS.
000539 Samuel J. Bolitho [Australie] ; Sharon L. Naismith ; Zoe Terpening ; Ron R. Grunstein ; Kerri Melehan ; Brendon J. Yee ; Alessandra Coeytaux ; Moran Gilat ; Simon J G. LewisInvestigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaire.
000561 Shekeeb S. Mohammad [Australie] ; Kate Sinclair ; Sekhar Pillai ; Vera Merheb ; Tim D. Aumann ; Deepak Gill ; Russell C. Dale ; Fabienne BrilotHerpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor.
000563 Martin B. Delatycki [Australie] ; Geneieve Tai ; Louise Corben ; Eppie M. Yiu ; Marguerite V. Evans-Galea ; Sarah E M. Stephenson ; Lyle Gurrin ; Katrina J. Allen ; David Lynch ; Paul J. LockhartHFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia.
000564 Julie C. Stout [Australie] ; Sarah Queller ; Kalyca N. Baker ; Sean Cowlishaw ; Cristina Sampaio ; Cheryl Fitzer-Attas ; Beth BorowskyHD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
000625 Kishore R. Kumar [Australie] ; Christine KleinCommentary for "Genetic Creutzfeldt-Jakob disease with R208H mutation presenting as progressive supranuclear palsy".
000630 Mark Walterfang [Australie] ; Bart P. Van De WarrenburgCognitive impairment in "Other" movement disorders: hidden defects and valuable clues.
000636 James R. Burrell [Australie] ; John R. Hodges ; James B. RoweCognition in corticobasal syndrome and progressive supranuclear palsy: a review.
000666 Ishani Sahama [Australie] ; Kate Sinclair ; Simona Fiori ; Kerstin Pannek ; Martin Lavin ; Stephen RoseAltered corticomotor-cerebellar integrity in young ataxia telangiectasia patients.
000669 Sun Ju Chung [Corée du Sud] ; Joanna M. Biernacka [États-Unis] ; Sebastian M. Armasu [États-Unis] ; Kari Anderson [États-Unis] ; Roberta Frigerio [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Anna Rita Bentivoglio [Italie] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Stefano Goldwurm [Italie] ; Georgios Hadjigeorgiou [Grèce] ; Barbara Jasinska-Myga [Pologne, États-Unis] ; Beom Seok Jeon [Corée du Sud] ; Yun Joong Kim [Corée du Sud] ; Rejko Krüger [Allemagne] ; Suzanne Lesage [France] ; Katerina Markopoulou [États-Unis] ; George Mellick [Australie] ; Karen E. Morrison ; Andreas Puschmann [Suède] ; Eng-King Tan [Singapour] ; Jessie Theuns [Belgique] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Alexis Elbaz [France] ; Demetrius M. Maraganore [États-Unis]Alpha-synuclein REP1 variants and survival in Parkinson’s disease
000705 Stefanie Reyes [Australie] ; Veronica Cottam ; Deniz Kirik ; Kay L. Double ; Glenda M. HallidayVariability in neuronal expression of dopamine receptors and transporters in the substantia nigra.
000724 Serene S. Paul [Australie] ; Colleen G. Canning ; Catherine Sherrington ; Stephen R. Lord ; Jacqueline C T. Close ; Victor S C. FungThree simple clinical tests to accurately predict falls in people with Parkinson's disease.
000785 Jeremy R B. Newman [Australie] ; Alexander C. Lehn ; Richard S. Boyle ; Peter A. Silburn ; George D. MellickScreening for rare sequence variants in the THAP1 gene in a primary dystonia cohort.
000813 Andrew H. Ford [Australie] ; Gordon W. Duncan ; Michael J. Firbank ; Alison J. Yarnall ; Tien K. Khoo ; David J. Burn ; John T. O'BrienRapid eye movement sleep behavior disorder in Parkinson's disease: magnetic resonance imaging study.
000815 Vaughan G. Macefield [Australie] ; Lucy J. Norcliffe-Kaufmann [États-Unis] ; Felicia B. Axelrod [États-Unis] ; Horacio Kaufmann [États-Unis]RELATIONSHIP BETWEEN PROPRIOCEPTION AT THE KNEE JOINT AND GAIT ATAXIA IN HSAN III
000837 Michael G. Heckman [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Jan O. Aasly [Norvège] ; Nadine Abahuni [Allemagne] ; Grazia Annesi ; Justin A. Bacon [États-Unis] ; Soraya Bardien [Afrique du Sud] ; Maria Bozi [Grèce] ; Alexis Brice [France] ; Laura Brighina [Italie] ; Jonathan Carr [Afrique du Sud] ; Marie-Christine Chartier-Harlin [France] ; Efthimios Dardiotis [Grèce] ; Dennis W. Dickson [États-Unis] ; Nancy N. Diehl [États-Unis] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Brian Fiske [États-Unis] ; J. Mark Gibson [Irlande (pays)] ; Rachel Gibson [Royaume-Uni] ; Georgios M. Hadjigeorgiou [Grèce] ; Nobutaka Hattori [Japon] ; Faycal Hentati [Tunisie] ; John P. A. Ioannidis [Grèce, États-Unis] ; Magdalena Boczarska-Jedynak [Pologne] ; Barbara Jasinska-Myga [Pologne] ; Beom S. Jeon [Corée du Sud] ; Yun Joong Kim [Corée du Sud] ; Christine Klein [Allemagne] ; Rejko Kruger [Allemagne] ; Elli Kyratzi [Grèce] ; Suzanne Lesage [France] ; Chin-Hsien Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Demetrius M. Maraganore [États-Unis] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Sung Sup Park [Corée du Sud] ; Simona Petrucci [Italie] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Young Ho Sohn [Corée du Sud] ; Leonidas Stefanis [Grèce] ; Vera Tadic [Allemagne] ; Jessie Theuns [Belgique] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Christine Van Broeckhoven [Belgique] ; Simone Van De Loo [Allemagne] ; Demetrios K. Vassilatis [Grèce] ; Carles Vilari O-Güell [Canada] ; Linda R. White [Norvège] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [Belgique] ; Ruey-Meei Wu [Taïwan] ; Matthew J. Farrer [Canada] ; Owen A. Ross [États-Unis]Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology Of Parkinson’s Disease (GEO-PD) consortium
000843 Alberto Albanese [Italie] ; Kailash Bhatia [Royaume-Uni] ; Susan B. Bressman [États-Unis] ; Mahlon R. Delong [États-Unis] ; Stanley Fahn [États-Unis] ; Victor S. C. Fung [Australie] ; Mark Hallett [États-Unis] ; Joseph Jankovic [États-Unis] ; H. A. Jinnah [États-Unis] ; Christine Klein [Allemagne] ; Anthony E. Lang [Canada] ; Jonathan W. Mink [États-Unis] ; Jan K. Teller [États-Unis]Phenomenology and classification of dystonia: a consensus update
000928 Ganesvaran Ganga [Australie] ; Jane E. Alty ; Benjamin G. Clissold ; Craig D. Mccoll ; Katrina A. Reardon ; Mark Schiff ; Peter A. KempsterLongitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase.
000956 Sharon L. Naismith [Australie] ; Loren Mowszowski ; Keri Diamond ; Simon J G. LewisImproving memory in Parkinson's disease: a healthy brain ageing cognitive training program.
000A41 Kirsten G. Coupland [Australie] ; Goerge D. Mellick [Australie] ; Peter A. Silburn [Australie] ; Karen Mather [Australie] ; Nicola J. Armstrong [Australie] ; Perminder S. Sachdev [Australie] ; Henry Brodaty [Australie] ; Yue Huang [Australie] ; Glenda M. Halliday [Australie] ; Marianne Hallupp [Australie] ; Woojin S. Kim [Australie] ; Carol Dobson-Stone [Australie] ; John B. J. Kwok [Australie]DNA Methylation of MAPT Gene in Parkinson's Disease Cohorts and Modulation by Vitamin E In Vitro
000A45 Sharon Kemp [Australie] ; Antony J. Harding ; Glenda M. Halliday ; Neil Mahant ; Victor S C. FungCortical limb myoclonus in pathologically proven progressive supranuclear palsy.
000A65 Nancy A. Pachana [Australie] ; Sarah J. Egan ; Ken Laidlaw ; Nadeeka Dissanayaka ; Gerard J. Byrne ; Simone Brockman ; Rodney Marsh ; Sergio StarksteinClinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease.
000A68 Liam Johnson [Australie] ; Ian James ; Julian Rodrigues ; Rick Stell ; Gary Thickbroom ; Frank MastagliaClinical and posturographic correlates of falling in Parkinson's disease.
000B22 Victor S. C. Fung [Australie] ; H. A. Jinnah [États-Unis] ; Kailash Bhatia [Royaume-Uni] ; Marie Vidailhet [France]ASSESSMENT OF THE PATIENT WITH ISOLATED OR COMBINED DYSTONIA: AN UPDATE ON DYSTONIA SYNDROMES
000B76 Ainhi D. Ha [Australie] ; Kaitlyn L. Parratt ; Nanna D. Rendtorff ; Marianne Lodahl ; Karl Ng ; Dominic B. Rowe ; Carolyn M. Sue ; Michael W. Hayes ; Lisbeth Tranebjaerg ; Victor S C. FungThe phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome.
000C14 Raymond S. Schwartz [Australie] ; Glenda M. Halliday ; Dennis J. Cordato ; Jillian J. KrilSmall-vessel disease in patients with Parkinson's disease: a clinicopathological study.
000C61 Brianada Koentjoro [Australie] ; Jin-Sung Park ; Ainhi Duy Ha ; Carolyn M. SuePhenotypic variability of parkin mutations in single kindred.
000D28 David A. Elliott [Australie] ; Woojin S. Kim ; Sarsha Gorissen ; Glenda M. Halliday ; John B J. KwokLeucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease.
000D41 James M. Shine [Australie] ; Glenda H. Halliday ; Mayra Carlos ; Sharon L. Naismith ; Simon J G. LewisInvestigating visual misperceptions in Parkinson's disease: a novel behavioral paradigm.
000E34 David R. Lynch [États-Unis] ; Massimo Pandolfo [Belgique] ; Jorg B. Schulz [Allemagne] ; Susan Perlman [États-Unis] ; Martin B. Delatycki [Australie] ; R. Mark Payne [États-Unis] ; Robert Shaddy [États-Unis] ; Kenneth H. Fischbeck [États-Unis] ; Jennifer Farmer [États-Unis] ; Paul Kantor [Canada] ; Subha V. Raman [États-Unis] ; Lisa Hunegs [États-Unis] ; Joanne Odenkirchen [États-Unis] ; Kristy Miller [États-Unis] ; Petra Kaufmann [États-Unis]Common Data Elements for Clinical Research in Friedreich Ataxia
000E43 Will Lee [Australie] ; David R. Williams ; Elsdon StoreyCognitive testing in the diagnosis of parkinsonian disorders: a critical appraisal of the literature.
000E84 Sergio E. Starkstein [Australie]Apathy in Parkinson's disease: diagnostic and etiological dilemmas.
000E85 Simon J G. Lewis [Australie] ; James M. Shine ; Shantel Duffy ; Glenda Halliday ; Sharon L. NaismithAnterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease.
000E91 Paul B. Tawadros [Australie] ; Dennis Cordato ; Ian Cathers ; John A. BurneAn electromyographic study of parkinsonian swallowing and its response to levodopa.
000F51 Ainhi D. Ha [Australie] ; Kaitlyn L. Parratt [Australie] ; Nanna D. Rendtorff [Danemark] ; Marianne Lodahl [Danemark] ; Karl Ng [Australie] ; Dominic B. Rowe [Australie] ; Carolyn M. Sue [Australie] ; Michael W. Hayes [Australie] ; Lisbeth Tranebjaerg [Danemark] ; Victor S. C. Fung [Australie]The Phenotypic Spectrum of Dystonia in Mohr-Tranebjaerg Syndrome
000F81 Raymond S. Schwartz [Australie] ; Glenda M. Halliday [Australie] ; Dennis J. Cordato [Australie] ; Jillian J. Kril [Australie]Small-Vessel Disease in Patients with Parkinson's Disease: A Clinicopathological Study
000F90 Leslie J. Cloud [États-Unis] ; Adam Rosenblatt [États-Unis] ; Russel L. Margolis [États-Unis] ; Christopher A. Ross [États-Unis] ; Jagan A. Pillai [États-Unis] ; Jody Corey-Bloom [États-Unis] ; Hannah M. Tully [États-Unis] ; Thomas Bird [États-Unis] ; Peter K. Panegyres [Australie] ; Charles A. Nichter [États-Unis] ; Donald S. Jr Higgins [États-Unis] ; Sandra L. Helmers [États-Unis] ; Stewart A. Factor [États-Unis] ; Randi Jones [États-Unis] ; Claudia M. Testa [États-Unis]Seizures in Juvenile Huntington's Disease: Frequency and Characterization in a Multicenter Cohort
001027 Brianada Koentjoro [Australie] ; Jin-Sung Park [Australie] ; Ainhi Duy Ha [Australie] ; Carolyn M. Sue [Australie]Phenotypic Variability of parkin Mutations in Single Kindred
001074 David A. Elliott [Australie] ; Woojin S. Kim [Australie] ; Sarsha Gorissen [Australie] ; Glenda M. Halliday [Australie] ; John B. J. Kwok [Australie]Leucine-Rich Repeat Kinase 2 and Alternative Splicing in Parkinson's Disease
001082 James M. Shine [Australie] ; Glenda H. Halliday [Australie] ; Mayra Carlos [Australie] ; Sharon L. Naismith [Australie] ; Simon J. G. Lewis [Australie]Investigating Visual Misperceptions in Parkinson's Disease: A Novel Behavioral Paradigm
001146 Monika Pötter-Nerger [Allemagne] ; Martin M. Reich [Allemagne] ; James G. Colebatch [Australie] ; G. Deuschl [Allemagne] ; Jens Volkmann [Allemagne]Differential Effect of Dopa and Subthalamic Stimulation on Vestibular Activity in Parkinson's Disease
001150 Meike Kasten [Allemagne] ; Lena Kertelge [Allemagne] ; Vera Tadic [Allemagne] ; Norbert Bruggemann [Allemagne] ; Alexander Schmidt [Allemagne] ; Joyce Van Der Vegt [Pays-Bas] ; Hartwig Siebner [Danemark] ; Carsten Buhmann [Allemagne] ; Rebekka Lencer [Allemagne] ; Kishore R. Kumar [Allemagne, Australie] ; Katja Lohmann [Allemagne] ; Johann Hagenah [Allemagne] ; Christine Klein [Allemagne]Depression and Quality of Life in Monogenic Compared to Idiopathic, Early-Onset Parkinson's Disease
001159 Luke A. Massey [Royaume-Uni] ; Caroline Micallef [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Helen Ling [Royaume-Uni] ; David R. Williams [Australie] ; Constantinos Kallis [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Tarek Yousry ; Med Habil [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] ; Hans R. J Ger [Royaume-Uni]Conventional Magnetic Resonance Imaging in Confirmed Progressive Supranuclear Palsy and Multiple System Atrophy
001165 Will Lee [Australie] ; David R. Williams [Australie] ; Elsdon Storey [Australie]Cognitive Testing in the Diagnosis of Parkinsonian Disorders: A Critical Appraisal of the Literature
001209 Sergio E. Starkstein [Australie]Apathy in Parkinson's Disease: Diagnostic and Etiological Dilemmas
001211 Simon J. G. Lewis [Australie] ; James M. Shine [Australie] ; Shantel Duffy [Australie] ; Glenda Halliday [Australie] ; Sharon L. Naismith [Australie]Anterior Cingulate Integrity: Executive and Neuropsychiatric Features in Parkinson's Disease
001214 Paul B. Tawadros [Australie] ; Dennis Cordato [Australie] ; Ian Cathers [Australie] ; John A. Burne [Australie]An Electromyographic Study of Parkinsonian Swallowing and Its Response to Levodopa
001241 Florence C. F. Chang [Australie] ; Prachi Mehta [Australie] ; Brianada Koentjoro [Australie] ; Mark Latt [Australie] ; Nick Blair [Australie] ; Garth Nicholson [Australie] ; Carolyn M. Sue [Australie] ; Victor S. C. Fung [Australie]"Dancing Feet Dyskinesias": A Clue to Parkin Gene Mutations
001273 Robert A. Wilcox [Australie] ; Susen Winkler [Allemagne] ; Katja Lohmann [Allemagne] ; Christine Klein [Allemagne]Whispering dysphonia in an Australian family (DYT4): A clinical and genetic reappraisal
001279 James M. Shine [Australie] ; Glenda M. Halliday [Australie] ; Sharon L. Naismith [Australie] ; Simon J. G. Lewis [Australie]Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?
001306 Keiran K. Tuck [Australie] ; Tow Chan Yeow [Australie] ; John G. L. Morris [Australie] ; Fran Baker [Australie] ; Victor S. C. Fung [Australie]The use of Fogs' test to assess associated movements in Parkinsonism, dystonia, and controls
001308 Nicola Z. Hobbs [Royaume-Uni] ; Amy V. Pedrick [Royaume-Uni] ; Miranda J. Say [Royaume-Uni] ; Chris Frost [Royaume-Uni] ; Rachelle Dar Santos [Canada] ; Allison Coleman [Canada] ; Aaron Sturrock [Canada] ; David Craufurd [Royaume-Uni] ; Julie C. Stout [Australie] ; Blair R. Leavitt [Canada] ; Josephine Barnes [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] ; Rachael I. Scahill [Royaume-Uni]The structural involvement of the cingulate cortex in premanifest and early Huntington's disease
001332 Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni]The effect of drug treatment on neurogenesis in Parkinson's disease
001364 Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie]Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study
001452 Giovanni Fabbrini [Italie] ; Marcello Merello [Argentine] ; Andrew H. Evans [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie]Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: Clinicopathological case
001462 Jasmine C. Menant [Australie] ; Mark D. Latt [Australie] ; Hylton B. Menz [Australie] ; Victor S. Fung [Australie] ; Stephen R. Lord [Australie]Postural sway approaches center of mass stability limits in Parkinson's disease
001463 Francisco Cardoso [Brésil] ; John Hodges [Australie] ; Andrew H. Evans [Australie] ; Tamas Revesz [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie]Postural instability, frontotemporal dementia, and ophthalmoplegia: Clinicopathological case
001468 Gun-Marie Hariz [Suède] ; Patricia Limousin [Royaume-Uni] ; Stephen Tisch [Australie] ; Marjan Jahanshahi [Royaume-Uni] ; Anncristine Fjellman-Wiklund [Suède]Patients' perceptions of life shift after deep brain stimulation for primary dystonia—A qualitative study
001489 Shen-Yang Lim [Malaisie] ; Michael J. Farrell [Australie] ; Andrew H. Evans [Australie]Parkinson's disease and pain—Nondopaminergic mechanisms are likely to be important too
001522 Sharon L. Naismith [Australie] ; Zoë Terpening [Australie] ; James M. Shine [Australie] ; Simon J. G. Lewis [Australie]Neuropsychological functioning in Parkinson's disease: Differential relationships with self‐reported sleep‐wake disturbances
001553 Hiroshi Shibasaki [Japon] ; Philip D. Thompson [Australie]Milestones in myoclonus
001561 Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis]Milestones in Parkinson's disease—Clinical and pathologic features
001587 Mark J. Edwards [Royaume-Uni] ; Araceli Alonso-Canovas [Royaume-Uni] ; Arnette Schrag [Royaume-Uni] ; Bastiaan R. Bloem [Pays-Bas] ; Philip D. Thompson [Australie] ; Kailash Bhatia [Royaume-Uni]Limb amputations in fixed dystonia: A form of body integrity identity disorder?
001615 Tracy Henderson [Australie] ; Nellie Georgiou-Karistianis [Australie] ; Owen White [Australie] ; Lynette Millist [Australie] ; David R. Williams [Australie] ; Andrew Churchyard [Australie] ; Joanne Fielding [Australie]Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease
001632 Sharon L. Naismith [Australie] ; Marilia Pereira [Australie] ; James M. Shine [Australie] ; Simon J. G. Lewis [Australie]How well do caregivers detect mild cognitive change in Parkinson's disease?
001647 Glenda M. Halliday [Australie] ; Claire H. Stevens [Australie]Glia: Initiators and progressors of pathology in Parkinson's disease
001662 Russell C. Dale [Australie] ; Julian J. Nasti [Australie] ; Greg B. Peters [Australie]Familial 7q21.3 microdeletion involving epsilon‐sarcoglycan causing myoclonus dystonia, cognitive impairment, and psychosis
001670 Mehrnaz Shoushtarian [Australie] ; Anna Murphy [Australie] ; Robert Iansek [Australie]Examination of central gait control mechanisms in Parkinson's disease using movement‐related potentials
001707 Sergio Starkstein [Australie] ; Milan Dragovic [Australie] ; Ricardo Jorge [États-Unis] ; Simone Brockman [Australie] ; Marcelo Merello [Argentine] ; Robert G. Robinson [États-Unis] ; David Bruce [Australie] ; Mark Wilson [Australie]Diagnostic criteria for depression in Parkinson's disease: A study of symptom patterns using latent class analysis
001718 Diane Ruge [Royaume-Uni] ; Stephen Tisch [Royaume-Uni, Australie] ; Marwan I. Hariz [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; John C. Rothwell [Royaume-Uni]Deep brain stimulation effects in dystonia: Time course of electrophysiological changes in early treatment
001731 Emma C. Schofield [Australie] ; John R. Hodges [Australie] ; Virginia Macdonald [Australie] ; Nicholas J. Cordato [Australie] ; Jillian J. Kril [Australie] ; Glenda M. Halliday [Australie]Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy
001749 Yun Ju Christine Song [Australie] ; Yue Huang [Australie] ; Glenda Margaret Halliday [Australie]Clinical correlates of similar pathologies in parkinsonian syndromes
001792 Natalie E. Allen [Australie] ; Catherine Sherrington [Australie] ; Serene S. Paul [Australie] ; Colleen G. Canning [Australie]Balance and falls in Parkinson's disease: A meta‐analysis of the effect of exercise and motor training
001807 Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Pablo Martinez-Martin [Espagne]Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale
001833 Kitty K. Wong [Australie] ; Jane E. Alty [Australie] ; Amanda G. Goy [Australie] ; Sanjay Raghav [Australie] ; David C. Reutens [Australie] ; Peter A. Kempster [Australie]A randomized, double‐blind, placebo‐controlled trial of levetiracetam for dyskinesia in Parkinson's disease
001911 David R. Williams [Australie, Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)?
001916 Sally M. Rosengren [Australie] ; James G. Colebatch [Australie]Vestibular evoked myogenic potentials are intact in cervical dystonia
001944 Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada]The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
001948 Sharon L. Naismith [Australie] ; James M. Shine [Australie] ; Simon J. G. Lewis [Australie]The specific contributions of set‐shifting to freezing of gait in Parkinson's disease
001962 Natalie E. Allen [Australie] ; Colleen G. Canning [Australie] ; Catherine Sherrington [Australie] ; Stephen R. Lord [Australie] ; Mark D. Latt [Australie] ; Jacqueline C. T. Close [Australie] ; Sandra D. O'Rourke [Australie] ; Susan M. Murray [Australie] ; Victor S. C. Fung [Australie]The effects of an exercise program on fall risk factors in people with Parkinson's disease: A randomized controlled trial
001989 Philippa Carter [Australie] ; Jenny Downs [Australie] ; Ami Bebbington [Australie] ; Simon Williams [Australie] ; Peter Jacoby [Australie] ; Walter E. Kaufmann [États-Unis] ; Helen Leonard [Australie]Stereotypical hand movements in 144 subjects with Rett syndrome from the population‐based Australian database
001A08 Stephany Fulda [Allemagne] ; Marie E. Beitinger [Allemagne] ; Simone Reppermund [Allemagne, Australie] ; Juliane Winkelmann [Allemagne] ; Thomas C. Wetter [Allemagne, Suisse]Short‐term attention and verbal fluency is decreased in restless legs syndrome patients
001A60 Kishore R. Kumar [Australie] ; Karl Ng [Australie]Reduced facial nerve hyperexcitability from contralateral cerebral stroke in hemifacial spasm
001A61 Sean S. O'Sullivan [Royaume-Uni] ; Andrew H. Evans [Australie] ; Niall P. Quinn [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Reckless generosity in Parkinson's disease
001A83 John W. Dunne [Australie] ; Barbara J. Singer [Australie] ; Peter L. Silbert [Australie] ; Kevin P. Singer [Australie]Prolonged vastus lateralis denervation after botulinum toxin type A injection
001A85 Ying Jiao Zhao ; Hwee Lin Wee ; Yiong-Huak Chan ; Soo Hoon Seah ; Wing Lok Au ; Puay Ngoh Lau ; Emmanuel Camara Pica ; Shu Chuen Li [Australie] ; Nan Luo ; Louis C. S. TanProgression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
001B56 Szu-Chia Lai ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen ; Chiung-Chu Chen ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song LuNeuronal intranuclear inclusion disease: Two cases of dopa‐responsive juvenile parkinsonism with drug‐induced dyskinesia
001B57 P. Ken Gillman [Australie]Neuroleptic malignant syndrome: Mechanisms, interactions, and causality
001C16 Alberto J. Espay [États-Unis] ; Dominic C. Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Robert E. Schmidt [États-Unis] ; Fredy J. Revilla [États-Unis] ; Leo Verhagen Metman [États-Unis] ; David Williams [États-Unis, Royaume-Uni, Australie]Juvenile levodopa‐responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment
001C34 Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Zeshan Ahmed [Royaume-Uni] ; Andrew H. Evans [Australie] ; Andrew D. Lawrence [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Impulsive‐compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy
001C60 Stephen Tisch [Australie] ; Bruce J. Brew [Australie]HIV, HAART, and Parkinson's disease: Co‐incidence or pathogenetic link?
001C88 Michael H. Cole [Australie] ; Peter A. Silburn [Australie] ; Joanne M. Wood [Australie] ; Charles J. Worringham [Australie] ; Graham K. Kerr [Australie]Falls in Parkinson's disease: Kinematic evidence for impaired head and trunk control
001D00 Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Andrew H. Evans [Australie] ; Clare M. Loane [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni]Excessive hoarding in Parkinson's disease
001D60 Patric Blomstedt [Suède] ; Ulrika Sandvik [Suède] ; Stephen Tisch [Australie]Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor
001D62 Eliana Della Flora [Australie] ; Caryn L. Perera [Australie] ; Alun L. Cameron [Australie] ; Guy J. Maddern [Australie]Deep brain stimulation for essential tremor: A systematic review
001D73 Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
001E44 Adam P. Vogel [Australie] ; Angela T. Morgan [Australie]Assessment of impairment or monitoring change in Friedreich ataxia
001E48 Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; John D. O'Sullivan [Australie] ; Peter A. Silburn [Australie] ; Gerard J. Byrne [Australie] ; Rodney Marsh [Australie] ; George D. Mellick [Australie]Anxiety disorders in Parkinson's disease: Prevalence and risk factors
001E76 Ainhi D. Ha [Australie] ; Carolyn Sue [Australie]ADEM presenting as a movement disorder
001E78 M. Kaye Trembath [Australie] ; Zoë A. Horton [Australie] ; Lynette Tippett [Nouvelle-Zélande] ; Virginia Hogg [Nouvelle-Zélande] ; Veronica R. Collins [Australie] ; Andrew Churchyard [Australie] ; Dennis Velakoulis [Australie] ; Richard Roxburgh [Nouvelle-Zélande] ; Martin B. Delatycki [Australie]A retrospective study of the impact of lifestyle on age at onset of Huntington disease
001E90 Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande]A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease
001F06 Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada]The α2 Adrenergic Antagonist Fipamezole Improves Quality of Levodopa Action in Parkinsonian Primates
001F20 YING JIAO ZHAO [Singapour] ; HWEE LIN WEE [Singapour] ; Yiong-Huak Chan [Singapour] ; SOO HOON SEAH [Singapour] ; WING LOK AU [Singapour] ; PUAY NGOH LAU [Singapour] ; Emmanuel Camara Pica [Singapour] ; SHU CHUEN LI [Australie] ; NAN LUO [Singapour] ; Louis C. S. Tan [Singapour]Progression of Parkinson's Disease as Evaluated by Hoehn and Yahr Stage Transition Times
001F30 P. Ken Gillman [Australie] ; Mrc Psych [Australie]Neuroleptic Malignant Syndrome: Mechanisms, Interactions, and Causality
001F60 Eliana Della Flora [Australie] ; Caryn L. Perera [Australie] ; Alun L. Cameron [Australie] ; Guy J. Maddern [Australie]Deep Brain Stimulation for Essential Tremor: A Systematic Review
001F88 Tanya Blekher [États-Unis] ; Marjorie R. Weaver [États-Unis] ; Jeanine Marshall [États-Unis] ; Siu Hui [États-Unis] ; Jacqueline Gray Jackson [États-Unis] ; Julie C. Stout [États-Unis, Australie] ; Xabier Beristain [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Robert D. Yee [États-Unis] ; Tatiana M. Foroud [États-Unis]Visual scanning and cognitive performance in prediagnostic and early‐stage Huntington's disease
001F92 Nadeeka N. W. Dissanayaka [Australie] ; Annabelle N. Sellebach [Australie] ; Sally Matheson [Australie] ; Rodney Marsh [Australie] ; John D. O'Sullivan [Australie] ; Peter A. Silburn [Australie] ; Gerard J. Byrne [Australie] ; George D. Mellick [Australie]Validity of a self‐rated method to identify a lifetime history of depression in Parkinson's disease
001F97 Natasha Mevawalla [Australie] ; Victor Fung [Australie] ; John Morris [Australie] ; Glenda Margaret Halliday [Australie]Unilateral rest tremor in vascular parkinsonism associated with a contralateral lesion of the locus coeruleus
002018 Sergio E. Starkstein [Australie] ; Marcelo Merello [Argentine] ; Ricardo Jorge [États-Unis] ; Simone Brockman [Australie] ; David Bruce [Australie] ; Brian Power [Australie]The syndromal validity and nosological position of apathy in Parkinson's disease
002058 Nadeeka N. W. Dissanayaka [Australie] ; Peter A. Silburn [Australie] ; John D. O'Sullivan [Australie] ; George D. Mellick [Australie]Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease
002087 Linda Truong [Australie] ; Daniel Brooks [Australie] ; Fabricio Amaral [Australie] ; Jasmine M. Henderson [Australie] ; Glenda M. Halliday [Australie]Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia
002105 Victor S. C. Fung [Australie] ; Lilie Herawati [Australie] ; Ying Wan [États-Unis]Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone
002107 Andrew H. Evans [Australie] ; James R. Stegeman [Australie]Punding in patients on dopamine agonists for restless leg syndrome
002152 Olav B. Nielssen [Australie] ; Raymond J. Cook [Australie] ; Ron Joffe [Australie] ; Linton J. Meagher [Australie] ; Paul Silberstein [Australie]Paraphilia and other disturbed behavior associated with dopamimetic treatment for Parkinson's disease
002182 Glenda Halliday [Australie] ; Maria Trinidad Herrero [Espagne] ; Karen Murphy [Australie] ; Heather Mccann [Australie] ; Francisco Ros-Bernal [Espagne] ; Carlos Barcia [Espagne] ; Hideo Mori [Japon] ; Francisco J. Blesa [Espagne] ; José A. Obeso [Espagne]No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism
002196 Anthony E. Lang [Canada] ; Michael Angel [Canada] ; Kailash Bhatia [Royaume-Uni] ; Robert Chen [Canada] ; Stanley Fahn [États-Unis] ; Mark Hallett [États-Unis] ; Anette Schrag [Royaume-Uni] ; Philip Thompson [Australie]Myoclonus in complex regional pain syndrome
002209 Kevin M. Biglan [États-Unis] ; Christopher A. Ross [États-Unis] ; Douglas R. Langbehn [États-Unis] ; Elizabeth H. Aylward [États-Unis] ; Julie C. Stout [Australie] ; Sarah Queller [États-Unis] ; Noelle E. Carlozzi [États-Unis] ; Kevin Duff [États-Unis] ; Leigh J. Beglinger [États-Unis] ; Jane S. Paulsen [États-Unis]Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study
002212 Prachi Mehta [Australie] ; George D. Mellick [Australie] ; Dominic B. Rowe [Australie] ; Glenda M. Halliday [Australie] ; Michael M. Jones [Australie] ; Neil Manwaring [Australie] ; Himesha Vandebona [Australie] ; Peter A. Silburn [Australie] ; Jie Jin Wang [Australie] ; Paul Mitchell [Australie] ; Carolyn M. Sue [Australie]Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community
002227 Jane E. Alty [Australie] ; Benjamin G. Clissold [Australie] ; Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]Longitudinal study of the levodopa motor response in Parkinson's disease: Relationship between cognitive decline and motor function
002243 Bhaskara P. Shelley [Royaume-Uni] ; John R. Hodges [Royaume-Uni, Australie] ; Christopher M. Kipps [Royaume-Uni] ; John H. Xuereb [Royaume-Uni] ; Thomas H. Bak [Royaume-Uni]Is the pathology of corticobasal syndrome predictable in life?
002257 Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis]Impulsive and compulsive behaviors in Parkinson's disease
002261 Davide Martino [Italie] ; Russell C. Dale [Australie] ; Donald L. Gilbert [États-Unis] ; Gavin Giovannoni [Royaume-Uni] ; James F. Leckman [États-Unis]Immunopathogenic mechanisms in tourette syndrome: A critical review
002281 Greg T. Sutherland [Australie] ; Gerhard A. Siebert [Australie] ; Jeremy R. B. Newman [Australie] ; Peter A. Silburn [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; George D. Mellick [Australie]Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease
002289 Ming-Jen Lee [Taïwan] ; Ignacio F. Mata [États-Unis] ; Chin-Hsien Lin [Taïwan] ; Kai-Yuan Tzen [Taïwan] ; Sarah J. Lincoln [États-Unis] ; Rebecca Bounds [États-Unis] ; Paul J. Lockhart [Australie] ; Mary M. Hulihan [États-Unis] ; Matthew J. Farrer [États-Unis] ; Ruey-Meei Wu [Taïwan]Genotype–phenotype correlates in Taiwanese patients with early‐onset recessive parkinsonism
002307 Annu Aggarwal [Australie] ; Jane E. Warren [Australie] ; Jason D. Warren [Australie] ; Philip D. Thompson [Australie]Facial reflex hyperexcitability in geniospasm suggests a brainstem origin
002336 Irene Martinez-Torres [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Steve Tisch [Australie] ; Rupert Page [Royaume-Uni] ; Ashwin Pinto [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Marwan I. Hariz [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni]Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life‐threatening dystonia
002351 Greg T. Sutherland [Australie] ; Glenda M. Halliday [Australie] ; Peter A. Silburn [Australie] ; Frank L. Mastaglia [Australie] ; Dominic B. Rowe [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; Tina Ly [Australie] ; Steve D. Wilton [Australie] ; George D. Mellick [Australie]Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
002357 Nan Luo ; Louis C. S. Tan ; Yingjiao Zhao ; Puay-Ngoh Lau ; Wing-Lok Au ; Shu Chuen Li [Australie]Determination of the longitudinal validity and minimally important difference of the 8‐item Parkinson's Disease Questionnaire (PDQ‐8)
002402 Mark D. Latt [Australie] ; Stephen R. Lord [Australie] ; John G. L. Morris [Australie] ; Victor S. C. Fung [Australie]Clinical and physiological assessments for elucidating falls risk in Parkinson's disease
002421 Natalie E. Allen [Australie] ; Colleen G. Canning [Australie] ; Catherine Sherrington [Australie] ; Victor S. C. Fung [Australie]Bradykinesia, muscle weakness and reduced muscle power in Parkinson's disease
002470 Sharavanan Parasivam [Australie] ; Max Cowey ; Bruce Day ; Dominic Thyagarajan [Australie]A unique case of cortical myoclonus sensitive to visual stimuli in the peripersonal space
002472 Meg E. Morris [Australie] ; Robert Iansek [Australie] ; Beth Kirkwood [Australie]A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease
002482 Patric Blomstedt [Suède] ; Marwan I. Hariz [Suède, Royaume-Uni] ; Stephen Tisch [Australie] ; Monica Holmberg [Suède] ; Tommy A. Bergenheim [Suède] ; Lars Forsgren [Suède]A family with a hereditary form of torsion dystonia from Northern Sweden treated with bilateral pallidal deep brain stimulation
002522 NAN LUO [Singapour] ; Louis C. S. Tan [Singapour] ; YINGJIAO ZHAO [Singapour] ; Puay-Ngoh Lau [Singapour] ; Wing-Lok Au [Singapour] ; SHU CHUEN LI [Australie]Determination of the Longitudinal Validity and Minimally Important Difference of the 8-item Parkinson's Disease Questionnaire (PDQ-8)
002588 Timothy J. Kleinig [Australie] ; Philip D. Thompson [Australie] ; Walid Matar [Australie] ; Andrew Duggins [Australie] ; Thomas E. Kimber [Australie] ; John G. Morris [Australie] ; Christopher S. Kneebone [Australie] ; Peter C. Blumbergs [Australie]The distinctive movement disorder of ovarian teratoma‐associated encephalitis
002598 Mariese A. Hely [Australie] ; Wayne G. J. Reid [Australie] ; Michael A. Adena [Australie] ; Glenda M. Halliday [Australie] ; John G. L. Morris [Australie]The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
002607 Andrea C. Solomon [États-Unis] ; Julie C. Stout [États-Unis, Australie] ; Marjorie Weaver [États-Unis] ; Sarah Queller [États-Unis] ; Allison Tomusk [États-Unis] ; Kathryn Burr Whitlock [États-Unis] ; Siu L. Hui [États-Unis] ; Jeanine Marshall [États-Unis] ; Jacqueline Gray Jackson [États-Unis] ; Eric R. Siemers [États-Unis] ; Xabier Beristain [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Tatiana Foroud [États-Unis]Ten‐year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease
002667 David R. Williams [Australie] ; Max Cowey [Australie] ; Kate Tuck [Australie] ; Bruce Day [Australie]Psychogenic propriospinal myoclonus
002797 Paul F. Sowman [Australie] ; Philip D. Thompson [Australie] ; Timothy S. Miles [Australie]Investigation of an unusual, high‐frequency jaw tremor with coherence analysis
002808 Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis]Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study
002817 Frances Huxham [Australie] ; Richard Baker [Australie] ; Meg E. Morris [Australie] ; Robert Iansek [Australie]Head and trunk rotation during walking turns in Parkinson's disease
002827 Meg E. Morris [Australie] ; Robert Iansek [Australie] ; Brook Galna [Australie]Gait festination and freezing in Parkinson's disease: Pathogenesis and rehabilitation
002836 Aileen K. Ho [Royaume-Uni] ; John L. Bradshaw [Australie] ; Robert Iansek [Australie]For better or worse: The effect of levodopa on speech in Parkinson's disease
002837 Frances Huxham [Australie] ; Richard Baker [Australie] ; Meg E. Morris [Australie] ; Robert Iansek [Australie]Footstep adjustments used to turn during walking in Parkinson's disease
002853 Karen E. Murphy [Australie] ; Tanya Karaconji [Australie] ; Craig D. Hardman [Australie] ; Glenda M. Halliday [Australie]Excessive dopamine neuron loss in progressive supranuclear palsy
002895 Richard Cordell [Australie] ; Hoe C. Lee [Australie] ; Andrew Granger [Australie] ; Barry Vieira [Australie] ; Andy H. Lee [Australie]Driving assessment in Parkinson's disease—A novel predictor of performance?
002900 Shen-Yang Lim [Australie] ; Michael J. Farrell [Australie] ; Stephen J. Gibson [Australie] ; Robert D. Helme [Australie] ; Anthony E. Lang [Canada] ; Andrew H. Evans [Australie]Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?
002918 Graham Kerr [Australie] ; Steven Morrison [États-Unis] ; Peter Silburn [Australie]Coupling between limb tremor and postural sway in Parkinson's disease
002985 Anna N. Sellbach [Australie] ; Andrew A. Wong [Australie] ; Richard S. Boyle [Australie]Ataxia due to isolated infarction of the precentral knob
002A00 Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Cristina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations
002A01 Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Christina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Anxiety rating scales in Parkinson's disease: Critique and recommendations
002A15 Mark Walterfang [Australie] ; Murat Yucel [Australie] ; Ruth Walker [États-Unis] ; Andrew Evans [Australie] ; Benedikt Bader [Allemagne] ; Ashley Ng [Australie] ; Adrian Danek [Allemagne] ; Ramon Mocellin [Australie] ; Dennis Velakoulis [Australie]Adolescent obsessive compulsive disorder heralding chorea‐acanthocytosis
002A26 Sergio E. Starkstein [Australie] ; Marcelo Merello [Argentine] ; Ricardo Jorge [États-Unis] ; Simone Brockman [Australie] ; David Bruce [Australie] ; Gustavo Petracca [Argentine] ; Robert G. Robinson [États-Unis]A validation study of depressive syndromes in Parkinson's disease
002B05 Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; Rodney Marsh [Australie] ; Peter A. Silburn [Australie] ; John D. O'Sullivan [Australie] ; Gerard J. Byrne [Australie] ; George D. Mellick [Australie]Validity of Hamilton depression inventory in Parkinson's disease
002B38 Michelle N. Mcdonnell [Australie] ; Philip D. Thompson [Australie] ; Michael C. Ridding [Australie]The effect of cutaneous input on intracortical inhibition in focal task‐specific dystonia
002B40 Sergio E. Starkstein [Australie] ; Marcelo Merello [Argentine]The Unified Parkinson's Disease Rating Scale: Validation study of the mentation, behavior, and mood section
002C37 David R. Williams [Australie, Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Kate Strand [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy
002C56 Yue Huang [Australie] ; Glenda M. Halliday [Australie] ; Himesha Vandebona [Australie] ; George D. Mellick [Australie] ; Frank Mastaglia [Australie] ; Julia Stevens [Australie] ; John Kwok [Australie] ; Michael Garlepp [Australie] ; Peter A. Silburn [Australie] ; Malcolm K. Horne [Australie] ; Katya Kotschet [Australie] ; Alison Venn [Australie] ; Dominic B. Rowe [Australie] ; Justin P. Rubio [Australie] ; Carolyn M. Sue [Australie]Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease
002D15 Kerrie L. Schoffer [Australie] ; Robert D. Henderson [Australie] ; Karen O'Maley [Australie] ; John D. O'Sullivan [Australie]Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease
002D76 Robert A. Wilcox [Australie] ; Andrew Churchyard [Australie] ; Henrik H. Dahl [Australie] ; Wendy M. Hutchison [Australie] ; Denise M. Kirby [Australie] ; Dominic Thyagarajan [Australie]Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions
002D97 Caroline Gurvich [Australie] ; Nellie Georgiou-Karistianis [Australie] ; Paul B. Fitzgerald [Australie] ; Lyn Millist [Australie] ; Owen B. White [Australie]Inhibitory control and spatial working memory in Parkinson's disease
002E01 Jim Grigsby [États-Unis] ; Angela G. Brega [États-Unis] ; Maureen A. Leehey [États-Unis] ; Glenn K. Goodrich [États-Unis] ; Sébastien Jacquemont [Suisse] ; Danuta Z. Loesch [Australie] ; Jennifer B. Cogswell [États-Unis] ; Jennifer Epstein [États-Unis] ; Rebecca Wilson [États-Unis] ; Tristan Jardini [États-Unis] ; Emma Gould [Australie] ; Rachael E. Bennett [États-Unis] ; David Hessl [États-Unis] ; Susannah Cohen [États-Unis] ; Kylee Cook [États-Unis] ; Flora Tassone [États-Unis] ; Paul J. Hagerman [États-Unis] ; Randi J. Hagerman [États-Unis]Impairment of executive cognitive functioning in males with fragile X‐associated tremor/ataxia syndrome
002E24 Julian P. Rodrigues [Australie] ; Susan E. Walters [Australie] ; Peter Watson [Australie] ; Rick Stell [Australie] ; Frank L. Mastaglia [Australie]Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease
002E87 Andrew H. Evans [Australie] ; Helmut Butzkueven [Australie]Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis
002E97 Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
002F04 Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Depression rating scales in Parkinson's disease: Critique and recommendations
002F39 Russell C. Dale [Australie] ; Richard Webster [Australie] ; Deepak Gill [Australie]Contemporary encephalitis lethargica presenting with agitated catatonia, stereotypy, and dystonia‐parkinsonism
002F56 Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France]Clinical diagnostic criteria for dementia associated with Parkinson's disease
002F90 James G. Colebatch [Australie]Bereitschaftspotential and movement‐related potentials: Origin, significance, and application in disorders of human movement
002F96 Arun V. Krishnan [Australie] ; Michael Hayes [Australie] ; Matthew C. Kiernan [Australie]Axonal excitability properties in hemifacial spasm
003058 Ruth M. Pickering [Royaume-Uni] ; Yvette A. M. Grimbergen [Pays-Bas] ; Una Rigney [Royaume-Uni] ; Ann Ashburn [Royaume-Uni] ; Gordon Mazibrada [Royaume-Uni] ; Brian Wood [Royaume-Uni] ; Peggy Gray [Canada] ; Graham Kerr [Australie] ; Bastiaan R. Bloem [Pays-Bas]A meta‐analysis of six prospective studies of falling in Parkinson's disease
003081 YUE HUANG [Australie] ; Glenda M. Halliday [Australie] ; Himesha Vandebona [Australie] ; George D. Mellick [Australie] ; Frank Mastaglia [Australie] ; Julia Stevens [Australie] ; John Kwok [Australie] ; Michael Garlepp [Australie] ; Peter A. Silburn [Australie] ; Malcolm K. Horne [Australie] ; Katya Kotschet [Australie] ; Alison Venn [Australie] ; Dominic B. Rowe [Australie] ; Justin P. Rubio [Australie] ; Carolyn M. Sue [Australie]Prevalence and clinical features of common LRRK2 mutations in australians with Parkinson's disease
003147 Robert Iansek [Australie] ; Frances Huxham [Australie] ; Jennifer Mcginley [Australie]The sequence effect and gait festination in Parkinson disease: Contributors to freezing of gait?
003176 Michelle J. Porritt [Australie] ; Ann E. Kingsbury [Royaume-Uni] ; Andrew J. Hughes [Australie] ; David W. Howells [Australie]Striatal dopaminergic neurons are lost with Parkinson's disease progression
003197 Jacques Montplaisir [Canada] ; Jeff Karrasch [Australie] ; Jean Haan [Allemagne] ; Dieter Volc [Autriche]Ropinirole is effective in the long‐term management of restless legs syndrome: A randomized controlled trial
003257 Charles J. Worringham [Australie] ; Joanne M. Wood [Australie] ; Graham K. Kerr [Australie] ; Peter A. Silburn [Australie]Predictors of driving assessment outcome in Parkinson's disease
003346 Uday B. Muthane [Inde] ; Yasha T. Chickabasaviah [Inde] ; Jasmine Henderson [Australie] ; Ann E. Kingsbury [Royaume-Uni] ; Linda Kilford [Royaume-Uni] ; Susarla K. Shankar [Inde] ; D. K. Subbakrishna [Inde] ; Andrew Lees (neurologue) [Royaume-Uni]Melanized nigral neuronal numbers in Nigerian and British individuals
003356 Benjamin G. Clissold [Australie] ; Craig D. Mccoll [Australie] ; Katrina R. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]Longitudinal study of the motor response to levodopa in Parkinson's disease
003467 Rene J. Stolwyk [Australie] ; Tom J. Triggs [Australie] ; Judith L. Charlton [Australie] ; Simon Moss [Australie] ; Robert Iansek [Australie] ; John L. Bradshaw [Australie]Effect of a concurrent task on driving performance in people with Parkinson's disease
003491 Ruth H. Walker [États-Unis] ; Adrian Danek [Allemagne] ; Carol Dobson-Stone [Australie] ; Renzo Guerrini [Italie] ; Hans H. Jung [Suisse] ; Anne-Louise Lafontaine [Canada] ; Luca Rampoldi [Italie] ; François Tison [France] ; Eva Andermann [Canada]Developments in neuroacanthocytosis: Expanding the spectrum of choreatic syndromes
003516 Kerrie L. Schoffer [Australie] ; John D. O'Sullivan [Australie] ; Jim Mcgill [Australie]Congenital disorder of glycosylation type Ia presenting as early‐onset cerebellar ataxia in an adult
003520 Nicholas J. Cordato [Australie] ; Glenda M. Halliday [Australie] ; Diana Caine [Australie] ; John G. L. Morris [Australie]Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease
003540 Sally M. Rosengren [Australie] ; James G. Colebatch [Australie]Cervical dystonia responsive to acoustic and galvanic vestibular stimulation
003563 Julian P. Rodrigues [Australie] ; Dylan J. Edwards [Australie] ; Susan E. Walters [Australie] ; Michelle L. Byrnes [Australie] ; Gary W. Thickbroom [Australie] ; Rick Stell [Australie] ; Frank L. Mastaglia [Australie]Blinded placebo crossover study of gabapentin in primary orthostatic tremor
003672 Belinda Bilney [Australie] ; Meg E. Morris [Australie] ; Andrew Churchyard [Australie] ; Edmond Chiu [Australie] ; Nellie Georgiou-Karistianis [Australie]Evidence for a disorder of locomotor timing in Huntington's disease
003704 Meg Morris [Australie] ; Robert Iansek [Australie] ; Jennifer Mcginley [Australie] ; Thomas Matyas [Australie] ; Frances Huxham [Australie]Three‐dimensional gait biomechanics in Parkinson's disease: Evidence for a centrally mediated amplitude regulation disorder
003714 Mariese A. Hely [Australie] ; John G. L. Morris [Australie] ; Wayne G. J. Reid [Australie] ; Robert Trafficante [Australie]Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
003715 Ann M. Bacsi [Australie] ; Victor S. C. Fung [Australie] ; James G. Colebatch [Australie]Sway patterns in orthostatic tremor: Impairment of postural control mechanisms
003722 Emma C. Schofield [Australie] ; Diana Caine [Australie] ; Jillian J. Kril [Australie] ; Nicholas J. Cordato [Australie] ; Glenda M. Halliday [Australie]Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration
003726 Mark Slee [Australie] ; Sharavanan Parasivam [Australie] ; Bill Blessing [Australie] ; Kate Truck [Australie] ; Bruce Day [Australie] ; Dominic Thyagarajan [Australie]Speech‐activated myoclonus: An uncommon form of action myoclonus
003760 Christopher M. Kipps [Australie] ; Victor S. C. Fung [Australie] ; Padraic Grattan-Smith [Australie] ; Gregory M. Demoore [Australie] ; John G. L. Morris [Australie]Reply: Akinetic crisis, acute akinesia, neuroleptic malignant‐like syndrome, Parkinsonism–hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal
003771 Nicole Limberg [Australie] ; Susanne Jeavons [Australie] ; Thomas Robertson [Australie] ; Richard Boyle [Australie]Pyramidal tract imaging in multiple‐system atrophy
003808 Yue Huang [Australie] ; Raymond Garrick [Australie] ; Raymond Cook [Australie] ; Dudley O'Sullivan [Australie] ; John Morris [Australie] ; Glenda M. Halliday [Australie]Pallidal stimulation reduces treatment‐induced dyskinesias in “minimal‐change” multiple system atrophy
003839 Christopher M. Kipps [Australie] ; Victor S. C. Fung [Australie] ; Padraic Grattan-Smith [Australie] ; Gregory M. De Moore [Australie] ; John G. L. Morris [Australie]Movement disorder emergencies
003890 Rene J. Stolwyk [Australie] ; Tom J. Triggs [Australie] ; Judith L. Charlton [Australie] ; Robert Iansek [Australie] ; John L. Bradshaw [Australie]Impact of internal versus external cueing on driving performance in people with Parkinson's disease
003909 Julian P. Rodrigues [Australie] ; Dylan J. Edwards [Australie] ; Susan E. Walters [Australie] ; Michelle L. Byrnes [Australie] ; Gary Thickbroom [Australie] ; Rick Stell [Australie] ; Frank L. Mastaglia [Australie]Gabapentin can improve postural stability and quality of life in primary orthostatic tremor
003948 Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie]Dopaminergic innervation of the human striatum in Parkinson's disease
003968 Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges
003A63 YUE HUANG [Australie] ; Raymond Garrick [Australie] ; Raymond Cook [Australie] ; Dudley O'Sullivan [Australie] ; John Morris [Australie] ; Glenda M. Halliday [Australie]Pallidal stimulation reduces treatment-induced dyskinesias in "minimal-change" multiple system atrophy
003B14 Ann M. Bacsi [Australie] ; G. Michael Halmagyi [Australie] ; James G. Colebatch [Australie]Sway patterns in a case of orthostatic tremor responsive to alcohol
003B40 Arthur S. Walters [États-Unis] ; William G. Ondo [États-Unis] ; Tilman Dreykluft [Allemagne] ; Ron Grunstein [Australie] ; Daniel Lee [États-Unis] ; Kapil Sethi [États-Unis]Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12‐week, double‐blind, randomized, parallel‐group, placebo‐controlled study
003B61 Brooke-Mai Whelan [Australie] ; Bruce E. Murdoch [Australie] ; Deborah G. Theodoros [Australie] ; Ross Darnell [Australie] ; Peter Silburn [Australie] ; Bruce Hall [Australie]Redefining functional models of basal ganglia organization: Role for the posteroventral pallidum in linguistic processing?
003B76 Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; Dominic Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Silke Appel [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
003B77 David R. Williams [Australie]Psychogenic palatal tremor
003C22 Jasmine Henderson [Australie] ; Michael Rodriguez [Australie] ; Dudley O'Sullivan [Australie] ; Malcolm Pell [Australie] ; Victor Fung [Australie] ; Alim-Louis Benabid [Australie, France] ; Glenda Halliday [Australie]Partial lesion of thalamic ventral intermediate nucleus after chronic high‐frequency stimulation
003C57 Peter A. Kempster [Australie]Michael J. Fox and his Parkinson's disease
003C63 Andrew H. Evans [Royaume-Uni] ; Durval C. Costa ; Sveto Gacinovic [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Simon Heales [Royaume-Uni] ; Phillip Lee [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings
003C71 George Mellick [Australie] ; Lee Price [Australie] ; Richard Boyle [Australie]Late‐onset presentation of pyruvate dehydrogenase deficiency
003C78 Elsdon Storey [Australie] ; Kate Tuck [Australie] ; Robert Hester [Australie] ; Andrew Hughes [Australie] ; Andrew Churchyard [Australie]Inter‐rater reliability of the International Cooperative Ataxia Rating Scale (ICARS)
003C89 Joanne Fielding [Australie] ; Nellie Georgiou-Karistianis [Australie] ; John Bradshaw [Australie] ; Lynette Millist [Australie] ; Andrew Churchyard [Australie] ; Edmond Chiu [Australie] ; Owen White [Australie]Impaired modulation of the vestibulo‐ocular reflex in Huntington's disease
003C98 Aileen K. Ho [Royaume-Uni, Australie] ; Anna O. G. Robbins [Royaume-Uni] ; Stephen J. Walters [Royaume-Uni] ; Stephen Kaptoge [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]Health‐related quality of life in Huntington's disease: A comparison of two generic instruments, SF‐36 and SIP
003D05 David R. Williams [Australie]Gaze‐evoked brainstem myoclonus
003D39 Dominic Thyagarajan [Australie] ; Timothy Chataway [Australie] ; Rong Li [États-Unis] ; Wei Ping Gai [Australie] ; Michael Brenner [États-Unis]Dominantly‐inherited adult‐onset leukodystrophy with palatal tremor caused by a mutation in the glial fibrillary acidic protein gene
003D67 Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Susan E. Daniel [Royaume-Uni] ; Andrew J. Hughes [Royaume-Uni, Australie] ; Tamas Révész [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis
003E58 Christopher M. Kipps [Australie] ; Victor S. C. Fung [Australie] ; Padraic Grattan-Smith [Australie] ; Gregory M. De Moore [Australie] ; John G. L. Morris [Australie]Movement disorder emergencies
003F57 Gary W. Thickbroom [Australie] ; Michelle L. Byrnes [Australie] ; Rick Stell [Australie] ; Frank L. Mastaglia [Australie]Reversible reorganisation of the motor cortical representation of the hand in cervical dystonia
003F91 Frank L. Mastaglia [Australie] ; Russell D. Johnsen [Australie] ; Michelle L. Byrnes [Australie] ; Byron A. Kakulas [Australie]Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's disease
004004 Vanessa K. Lim [Nouvelle-Zélande, Allemagne] ; John L. Bradshaw [Australie] ; Michael E. R. Nicholls [Australie] ; Eckart Altenmüller [Allemagne]Perceptual differences in sequential stimuli across patients with musician's and writer's cramp
004030 Jane E. Warren [Australie] ; Marie Vidailhet [France] ; Christopher S. Kneebone [Australie] ; Niall P. Quinn [Royaume-Uni] ; Philip D. Thompson [Australie]Myoclonus in spinal dysraphism
004083 Neil Mahant [Australie] ; Dennis J. Cordato [Australie] ; Victor S. C. Fung [Australie]Focal myoclonus‐dystonia of the leg secondary to a lesion of the posterolateral putamen: Clinical and neurophysiological features
004167 Jason D. Warren [Australie] ; Thomas E. Kimber [Australie] ; Philip D. Thompson [Australie]Brainstem myoclonus in generalised tetanus
004182 Florian A. Kagerer [Australie] ; Jeff J. Summers [Australie] ; Winston D. Byblow [Nouvelle-Zélande] ; Bruce Taylor [Australie]Altered corticomotor representation in patients with Parkinson's disease
004241 Simon G. Parkin [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Peter Silburn [Australie] ; Bruce Hall [Australie] ; Richard Boyle [Australie] ; Carole Joint [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni]Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: A case series of 115 patients
004242 Padraic J. Grattan-Smith [Australie] ; Ron A. Wevers [Pays-Bas] ; Gerry C. Steenbergen-Spanjers [Pays-Bas] ; Victor S. C. Fung ; John Earl [Australie] ; Bridget Wilcken [Australie]Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancy
004281 Hans-Michael Meinck [Allemagne] ; Philip D. Thompson [Australie]Stiff man syndrome and related conditions
004291 Kin-Lun Tsang [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Rick Stell [Australie] ; Peter Brown [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Sixty‐Six‐Year‐Old woman with unexplained falls followed five years later by severe generalized myoclonus
004295 Virginia Macdonald [Australie] ; Glenda M. Halliday [Australie]Selective loss of pyramidal neurons in the pre‐supplementary motor cortex in Parkinson's disease
004308 Allan J. Mclean [Australie] ; Patrick PurcellReply
004325 Frank L. Mastaglia [Australie] ; Russell D. Johnsen [Australie] ; Byron A. Kakulas [Australie]Prevalence of stroke in Parkinson's disease: A postmortem study
004329 Ann L. Smiley-Oyen [États-Unis] ; Charles J. Worringham [Australie] ; Carol L. Cross [États-Unis]Practice effects in three‐dimensional sequential rapid aiming in Parkinson's disease
004335 Jasmine M. Henderson [Australie] ; Malcolm Pell [Australie] ; Dudley J. O'Sullivan [Australie] ; Elizabeth A. Mccusker [Australie] ; Victor S. C. Fung [Australie] ; Philippa Hedges [Australie] ; Glenda M. Halliday [Australie]Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease
004380 Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease
004451 Danqing Zhu [Australie] ; Christopher Burke [Australie] ; Anthony Leslie [Australie] ; Garth A. Nicholson [Australie]Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion
004457 Shaun R. D. Watson [Australie] ; James G. Colebatch [Australie]Focal pathological startle following pontine infarction
004474 Alexander Fisher [Australie] ; James Croft-Baker [Australie] ; Michael Davis [Australie] ; Patrick Purcell [Australie] ; Allan J. Mclean [Australie]Entacapone‐Induced Hepatotoxicity and Hepatic Dysfunction
004478 Cumhur Ertekin [Turquie] ; Sultan Tarlaci [Turquie] ; Ibrahim Aydogdu [Turquie] ; Nefati Kiylioglu [Turquie] ; Nur Yuceyar [Turquie] ; A. Bulent Turman [Australie] ; Yaprak Secil [Turquie] ; Figen Esmeli [Turquie]Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease
004485 Katherine A. Johnson [Australie] ; Ross Cunnington [Australie, Royaume-Uni] ; John L. Bradshaw [Australie] ; Edmond Chiu [Australie] ; Robert Iansek [Australie]Effect of an attentional strategy on movement‐related potentials recorded from subjects with Huntington's disease
004496 Monica J. Ling [Australie] ; Arun Aggarwal [Australie] ; John G. L. Morris [Australie]Dopa‐responsive parkinsonism secondary to right temporal lobe haemorrahage
004502 J. E. Rice [Australie] ; R. Antic [Australie] ; Philip D. Thompson [Australie]Disordered respiration as a levodopa‐induced dyskinesia in Parkinson's disease
004553 Peter J. Healy [Australie] ; Kerrie D. Pierce [Australie] ; Julie A. Dennis [Australie] ; Peter A. Windsor [Australie] ; Peter R. Schofield [Australie]Bovine myoclonus: Model of human hyperekplexia (Startle disease)
004556 Winston D. Byblow [Nouvelle-Zélande] ; Jeffery J. Summers [Australie] ; Gwyn N. Lewis [Nouvelle-Zélande] ; Julie Thomas [Australie]Bimanual coordination in Parkinson's disease: Deficits in movement frequency, amplitude, and pattern switching
004566 John G. L Morris [Australie] ; Padraic Grattan-Smith [Australie] ; Stacey K. Jankelowitz [Australie] ; Victor S. C. Fung [Australie] ; Paul D. Clouston [Australie] ; Michael W. Hayes [Australie]Athetosis II: The syndrome of mild athetoid cerebral palsy
004567 John G. L Morris [Australie] ; Stacey K. Jankelowitz [Australie] ; Victor S. C. Fung [Australie] ; Paul D. Clouston [Australie] ; Michael W. Hayes [Australie] ; Padraic Grattan-Smith [Australie]Athetosis I: Historical considerations
004592 Padraic J. Grattan-Smith [Australie] ; Ron A. Wevers [Pays-Bas] ; Gerry C. Steenbergen-Spanjers [Pays-Bas] ; Victor S. C. Fung [Australie] ; John Earl [Australie] ; Bridget Wilcken [Australie]Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancy
004600 Ann L. Smiley-Oyen [États-Unis] ; Charles J. Worringham [Australie] ; Carol L. Cross [États-Unis]Practice effects in three-dimensional sequential rapid aiming in Parkinson's disease
004614 DANQING ZHU [Australie] ; Christopher Burke [Australie] ; Anthony Leslie [Australie] ; Garth A. Nicholson [Australie]Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion
004707 William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie]Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuations
004731 Jasmine M. Henderson [Australie] ; Wei Ping Gai [Australie] ; Mariese A. Hely [Australie] ; Wayne G. J. Reid [Australie] ; Grant L. Walker [Australie] ; Glenda M. Halliday [Australie]Parkinson's disease with late Pick's dementia
004746 James W. Lance [Australie] ; Raymond D. Adams [États-Unis]Negative myoclonus in posthypoxic patients: Historical note
004750 R. Cunnington [Australie] ; G. F. Egan [Australie] ; J. D. O'Sullivan [Australie] ; A. J. Hughes [Australie] ; J. L. Bradshaw [Australie] ; J. G. Colebatch [Australie]Motor imagery in Parkinson's disease: A PET study
004814 Peter Brown [Royaume-Uni] ; Philip D. Thompson [Australie]Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor
004815 J. D. Warren [Australie] ; T. E. Kimber [Australie] ; P. C. Blumbergs [Australie] ; P. D. Thompson [Australie]Eighty‐nine‐year‐old man with generalised chorea and basal ganglia mineralization
004833 N. J. Cordato [Australie] ; G. M. Halliday [Australie] ; H. Mccann [Australie] ; L. Davies [Australie] ; P. Williamson [Australie] ; M. Fulham [Australie] ; J. G. L. Morris [Australie]Corticobasal syndrome with tau pathology
004843 Peter J. Hand [Australie] ; R. J. Mckinlay Gardner [Australie] ; Melanie A. Knight [Australie] ; Susan M. Forrest [Australie] ; Elsdon Storey [Australie]Clinical features of a large Australian pedigree with episodic ataxia type 1
004920 Aileen K. Ho [Australie] ; John L. Bradshaw [Australie] ; Robert Iansek [Australie]Volume perception in Parkinsonian speech
004978 Stacey K. Jankelowitz [Australie] ; Paul D. Clouston [Australie]Radiation‐induced ‘Meige Syndrome’
004984 Victor S. C. Fung [Australie] ; Andrew Duggins [Australie] ; John G. L. Morris [Australie] ; Ivan T. Lorentz [Australie]Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia
004A11 Victor S. C. Fung [Australie] ; John A. Burne [Australie] ; John G. L. Morris [Australie]Objective quantification of resting and activated parkinsonian rigidity: A comparison of angular impulse and work scores
004A23 D. M. Sheppard [Royaume-Uni, Australie] ; J. L. Bradshaw [Australie] ; N. Georgiou [Australie] ; J. A. Bradshaw [Australie] ; P. Lee [Australie]Movement sequencing in children with Tourette's syndrome and attention deficit hyperactivity disorder
004A32 Maria Teresa Dotti [Italie] ; Carla Battisti [Italie] ; Alessandro Malandrini [Italie] ; Antonio Federico [Italie] ; Justin P. Rubio [Australie] ; Giuseppe Circiarello [Italie] ; Anthony P. Monaco [Royaume-Uni]McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene
004A54 T. E. Kimber [Australie] ; P. D. Thompson [Australie]Increased blink rate in advanced Parkinson's disease: A form of ‘off’‐period dystonia?
004B47 Paul Mccrory [Australie]An unusual cause of gait disturbance in an elite sprinter
004C10 George D. Mellick [Australie] ; Daniel D. Buchanan [Australie] ; Sally J. Mccann [Australie] ; Kristy M. James [Australie] ; Anthony G. Johnson [Australie] ; Darren R. Davis [Australie] ; Nanay Liyou [Australie] ; Daniel Chan [Australie] ; David G. Le Couteur [Australie]Variations in the monoamine oxidase B lpar;MAOB) gene are associated with Parkinson's disease
004C26 Craig D. Hardman [Australie] ; Glenda M. Halliday [Australie]The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy
004C80 Alfredo Berardelli [Italie] ; Johannes Noth ; Philip D. Thompson [Australie] ; Eduard L. E. M. Bollen [Pays-Bas] ; Antonio Currà [Italie] ; Gunther Deuschl [Allemagne] ; J. Gert Van Dijk [Pays-Bas] ; Rudolf Töpper ; Michael Schwarz ; Raymund A. C. Roos [Pays-Bas]Pathophysiology of chorea and bradykinesia in Huntington's disease
004C92 Bahman Jabbari [États-Unis] ; Arash Salardini [Australie]Painful tonic/dystonic spasms in Sjogren's syndrome
004D04 Ross Cunnington [Australie] ; Robert Iansek [Australie] ; John L. Bradshaw [Australie]Movement‐related potentials in Parkinson's disease: External cues and attentional strategies
004D47 Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]Evolution of motor fluctuations in Parkinson's disease: A longitudinal study over 6 years
004D70 Nellie Georgiou [Australie] ; John L. Bradshaw [Australie] ; Edmond Chiu [Australie] ; Anne Tudor [Australie] ; Louise O'Gorman [Australie] ; Jim G. Phillips [Australie]Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease
004E21 Michael W. Hayes ; Shanti Graham ; Peter Heldorf ; Gregory De Moore [Australie] ; John G. L. MorrisA video review of the diagnosis of psychogenic gait: Appendix and commentary
004E68 Michael W. Hayes ; Robert A. Ouvrier ; William Evans [Australie] ; Ernest Somerville ; MorrisX‐linked dystonia‐deafness syndrome
004E95 Sachdev [Australie]Tardive blepharospasm
004F17 Cordato [Australie] ; Michael J. Fulham [Australie] ; Con Yiannikas [Australie]Pretreatment and posttreament positron emission tomographic scan imaging in a 20‐year‐old patient with Wilson's disease
004F68 Ali H. Rajput [Canada] ; Alex Rajput [Canada] ; Anthony E. Lang [Canada] ; Rajeev Kumar [Canada] ; Ryan J. Uitti [États-Unis] ; David G. Le Couteur [Australie] ; Sally J. Mccann [Australie] ; Mark W. Becher [États-Unis] ; Christopher A. Ross [États-Unis] ; Richard Hardie [Royaume-Uni]Letters to the Editor
004F73 Lagopoulos [Australie] ; Paul Clouston [Australie] ; Homayoun Barhamali [Australie] ; Evian Gordon [Australie] ; Waiman M. Li [Australie] ; Julian Lesley [Australie] ; John G. L. Morris [Australie]Late components of the event‐related potentials and their topography in Parkinson's disease
004F99 John D. O'Sullivan [Australie] ; Catherine M. Said [Australie] ; Louise C. Dillon [Australie] ; Marion Hoffman [Australie] ; Hughes [Australie]Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function
005025 Jason Warren [Australie] ; Thompson [Australie]Drug‐induced supraglottic dystonia and spasmodic dysphonia
005069 John D. O'Sullivan [Australie] ; Andrew J. Hughes [Australie]Apomorphine‐induced penile erections in Parkinson's disease
005078 James W. Lance [Australie] ; Ian Hickie [Brésil] ; Denis Wakefield [Australie] ; Colebatch [Australie] ; Francisco Cardoso [Brésil] ; Marie Vidailhet [France]An akinetic‐rigid syndrome, depression, and stereotypies in a young man
005091 Morris ; Robert Iansek ; Thomas Matyas ; Jeffery Summers [Australie]Abnormalities in the stride length‐cadence relation in parkinsonian gait
005111 P. Sachdev [Australie]Tardive blepharospasm
005125 D. J. Cordato [Australie] ; M. J. Fulham [Australie] ; C. Yiannikas [Australie]Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease
005142 J. Lagopoulos [Australie] ; P. Clouston [Australie] ; H. Barhamali [Australie] ; E. Gordon [Australie] ; W. M. Li [Australie] ; J. Lesley [Australie] ; J. G. L. Morris [Australie]Late components of the event-related potentials and their topography in Parkinson's disease
005193 M. Morris [Australie] ; R. Iansek [Australie] ; T. Matyas [Australie] ; J. Summers [Australie]Abnormalities in the stride length-cadence relation in parkinsonian gait
005234 Grattan‐Smith [Australie] ; B. Wilcken [Australie] ; P. G. Procopis [Australie] ; G. A. Wise [Australie]The neurological syndrome of infantile cobalamin deficiency: Developmental regression and involuntary movements
005241 Werhahn [Royaume-Uni, Allemagne] ; Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni, Australie] ; C. D. Marsden [Royaume-Uni]The clinical features and prognosis of chronic posthypoxic myoclonus
005246 Elsdon Storey [Australie] ; John Lloyd [Australie]Tardive tremor
005250 Kimber [Australie] ; Philip D. Thompson [Australie]Symptomatic hyperekplexia occurring as a result of pontine infarction
005258 Merello [Argentine] ; Andrew Hughes [Australie] ; Carlo Colosimo [Argentine] ; Marion Hoffman [Australie] ; Sergio Starkstein [Argentine] ; Ramon Leiguarda [Argentine]Sleep benefit in parkinson's disease
005322 Anthony Feinstein [Canada] ; C. M. Sue [Australie] ; J. G. L. Morris [Australie] ; John G. Nutt [États-Unis] ; Stephen T. Gancher [États-Unis] ; Anthony E. Lang [Canada] ; Tetsuo Ashizawa [États-Unis] ; Joseph Jankovic [États-Unis]Letters to the editor
005335 Georgiou ; Jim G. Phillips ; John L. Bradshaw ; Ross Cunnington ; Edmond Chiu [Australie]Impairments of movement kinematics in patients with Huntington's disease: A comparison with and without a concurrent task
005381 Victor S. C. Fung [Australie] ; Morris [Australie] ; Jonathan Leicester [Australie] ; Y. S. Soo [Australie] ; Llewelyn Davies [Australie]Clonic perseveration following thalamofrontal disconnection: A distinctive movement disorder
005400 le Couteur [Australie] ; Peter W. Leighton [Australie] ; Sally J. Mccann [Australie] ; Susan M. Pond [Australie]Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease
005447 P. J. Grattan-Smith [Australie] ; B. Wilcken [Australie] ; P. G. Procopis [Australie] ; G. A. Wise [Australie]The neurological syndrome of infantile cobalamin deficiency : Developmental regression and involuntary movements
005453 E. Storey [Australie] ; J. Lloyd [Australie]Tardive tremor
005455 T. E. Kimber [Australie] ; P. D. Thompson [Australie]Symptomatic hyperekplexia occurring as a result of pontine infarction
005461 M. Merello [Argentine] ; A. Hughes [Australie] ; C. Colosimo [Argentine] ; M. Hoffman [Australie] ; S. Starkstein [Argentine] ; R. Leiguarda [Argentine]Sleep benefit in Parkinson's disease
005496 N. Georgiou [Australie] ; J. G. Phillips [Australie] ; J. L. Bradshaw [Australie] ; R. Cunnington [Australie] ; E. Chiu [Australie]Impairments of movement kinematics in patients with Huntington's disease : A comparison with and without a concurrent task
005538 D. G. Le Couteur [Australie] ; P. W. Leighton [Australie] ; S. J. Mccann [Australie] ; S. M. Pond [Australie]Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease
005687 P. D. Clouston ; C. L. Lim ; V. Fung ; C. Yiannikas ; Morris [Australie]Brainstem myoclonus in a patient with non‐dopa‐responsive parkinsonism
005707 P. D. Thompson [Australie]Anita Harding. (1952–1995)
005814 Stell [Australie] ; G. W. Thickbroom [Australie] ; F. L. Mastaglia [Australie]The audiogenic startle response in Tourette's syndrome
005838 Georgiou [Australie] ; John L. Bradshaw [Australie] ; Jim G. Phillips [Australie] ; Edmond Chiu [Australie] ; Judy A. Bradshaw [Australie]Reliance on advance information and movement sequencing in huntington's disease
005881 Perminder Sachdev [Australie] ; Anthony E. Lang [Canada]Letters to the editor
005919 Colebatch [Australie] ; V. Di Lazzaro [Royaume-Uni] ; A. Quartarone [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; M. Gresty [Royaume-Uni]Click‐evoked vestibulocollic reflexes in torticollis
005970 R. Stell [Australie] ; G. W. Thickbroom ; F. L. MastagliaThe audiogenic startle response in Tourette's syndrome
005984 N. Georgiou [Australie] ; J. L. Bradshaw [Australie] ; J. G. Phillips [Australie] ; E. Chiu ; J. A. Bradshaw [Australie]Reliance on advance information and movement sequencing in Huntington's disease
005A23 J. G. Colebatch [Australie] ; V. Di Lazzaro ; A. Quartarone ; J. C. Rothwell ; M. GrestyClick-evoked vestibulocollic reflexes in torticollis
005A71 J. N. Caviness [Royaume-Uni] ; A. Gabellini [Royaume-Uni] ; C. S. Kneebone [Australie] ; P. D. Thompson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marsden [Royaume-Uni]Unusual focal dyskinesias: The ears, the shoulders, the back, and the abdomen
005C04 Phillips [Australie] ; J. L. Bradshaw [Australie] ; E. Chiu [Australie] ; J. A. Bradshaw [Australie]Characteristics of handwriting of patients with huntington's disease
005C87 J. G. Phillips [Australie] ; J. L. Bradshaw ; E. Chiu ; J. A. BradshawCharacteristics of handwriting of patients with Huntington's disease
005D20 Sachdev [Australie]Tardive and chronically recurrent oculogyric crises
005D37 M. A. Hely [Australie] ; T. Chey [Australie] ; A. Wilson [Australie] ; P. M. Williamson [Australie] ; D. J. O'Sullivan [Australie] ; D. Rail [Australie] ; Morris [Australie]Reliability of the columbia scale for assessing signs of parkinson's disease
005E46 P. Sachdev [Australie]Tardive and chronically recurrent oculogyric crises
005F36 Davies [Australie] ; P. J. L. King [Australie] ; J. Leicester [Australie] ; J. G. L. Morris [Australie]Recumbent tic
006016 Sachdev [Australie]Golfers' cramp: Clinical characteristics and evidence against it being an anxiety disorder
006069 L. Davies [Australie] ; P. J. L. King ; J. Leicester ; J. G. L. MorrisRecumbent tic
006094 P. Sachdev [Australie]Golfers' cramp: clinical characteristics and evidence against it being an anxiety disorder
006116 Lorentz [Australie] ; S. Shanthi Subramaniam [Australie] ; C. Yiannikas [Australie]Treatment of idiopathic spasmodic torticollis with botulinum toxin a: A double‐blind study on twenty‐three patients
006214 I. T. Lorentz [Australie] ; S. Shanthi Subramaniam ; C. YiannikasTreatment of idiopathic spasmodic torticollis with botulinum toxin A : a double-blind study on twenty-three patients
006344 Herzberg [Australie]An essay on the shaking palsy: Reviews and notes on the journals in which they appeared

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024